Status:
UNKNOWN
Paracetamol Versus Ibuprofen for PDA Closure
Lead Sponsor:
Ain Shams University
Conditions:
Patent Ductus Arteriosus
Eligibility:
All Genders
28-35 years
Phase:
PHASE4
Brief Summary
Comparison between the safety and efficacy of oral paracetamol and oral ibuprofen in treatment of Patent Ductus Arteriosus (PDA) in premature infants
Detailed Description
A pilot study through which we have studied efficacy and safety of oral paracetamol and oral ibuprofen in treatment of hemodyamically significant pda in preterm neonates. 30 preterm neonates were incl...
Eligibility Criteria
Inclusion
- Gestational age ≤ 35 weeks
- Aged 2-7 days with color Doppler echocardiographic evidence of PDA
- Urine output more than 1 ml/kg/hr
- Creatinine concentration level less than 1.8 mg/dl
Exclusion
- Neonates who have one or more of the following criteria were excluded from the study:
- Congenital heart diseases of any type including
- Pulmonary stenosis
- Anomalus in pulmonary venous drainage
- Ventricular septal defect
- Major congenital anomalies as hydrops fetalis
- Low platelets count (less than 60, 000/mm3)
Key Trial Info
Start Date :
June 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03265782
Start Date
June 1 2015
End Date
January 1 2018
Last Update
August 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.